Literature DB >> 12687655

Weighting in instrumental variables and G-estimation.

Marshall M Joffe1, Colleen Brensinger.   

Abstract

We propose here a simple scheme to use information on compliance and prerandomization covariates to improve analysis of randomized trials with non-compliance. We use the data to determine the effect of randomization on treatment received among various strata defined by pretreatment covariates. When the effect of treatment received on the outcome of interest is the same across strata and pretreatment covariates predict non-compliance, weighting the estimating functions by the effect of randomization on treatment received can improve the precision of explanatory estimates of treatment effect and can increase the power of intent-to-treat tests of the null hypothesis. Efficiency gains under the weighting scheme are a simple increasing function of the variability of these weights. Such weighting schemes will often lead to improvements even when these conditions are not met. We use a randomized trial of cholestyramine to illustrate these points. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687655     DOI: 10.1002/sim.1380

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Longitudinal structural mixed models for the analysis of surgical trials with noncompliance.

Authors:  Colleen M Sitlani; Patrick J Heagerty; Emily A Blood; Tor D Tosteson
Journal:  Stat Med       Date:  2012-02-17       Impact factor: 2.373

2.  Estimating the efficacy of an interstitial cystitis/painful bladder syndrome medication in a randomized trial with both non-adherence and loss to follow-up.

Authors:  Wei Yang; Kathleen J Propert; J Richard Landis
Journal:  Stat Med       Date:  2012-12-10       Impact factor: 2.373

3.  Using an instrumental variable to test for unmeasured confounding.

Authors:  Zijian Guo; Jing Cheng; Scott A Lorch; Dylan S Small
Journal:  Stat Med       Date:  2014-06-15       Impact factor: 2.373

4.  Gene-environment interaction testing in family-based association studies with phenotypically ascertained samples: a causal inference approach.

Authors:  David W Fardo; Jinze Liu; Dawn L Demeo; Edwin K Silverman; Stijn Vansteelandt
Journal:  Biostatistics       Date:  2011-11-13       Impact factor: 5.279

5.  Estimating efficacy in trials with selective crossover.

Authors:  Adam R Brentnall; Peter Sasieni; Jack Cuzick
Journal:  Stat Med       Date:  2017-03-15       Impact factor: 2.373

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.